Vertex Reports Second-Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Americold to wind down Ahold Delhaize facilities, take $305M charge
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Did Google and Tesla just break AI trade’s bull case?
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- Matador Resources to acquire Paloma Permian for $1.275B
Vertex Pharma (VRTX) Tops Q2 EPS by 83c
July 29, 2021 4:03 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q2 EPS of $3.11, $0.83 better than the analyst estimate of $2.28. Revenue for the quarter came in at $1.79 billion versus the consensus estimate of $1.72 billion.
GUIDANCE:
Vertex Pharma sees FY2021 revenue of $7.2-7.4 billion, versus the consensus... More
